查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1631117

創傷後壓力症候群治療市場規模、佔有率、趨勢分析報告：按藥物類別、人口統計、分銷管道、地區、細分市場、預測，2025-2030 年

Post-traumatic Stress Disorder Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Demographics, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

創傷後壓力症候群治療市場的成長與趨勢

根據 Grand View Research, Inc. 的一份新報告，全球創傷後壓力症候群治療市場規模預計到 2030 年將達到 28.5 億美元。

預計 2025 年至 2030 年間，市場複合年成長率為 4.08%。創傷後壓力症候群（PTSD）的疾病負擔不斷加重、研發和新藥管道的技術進步以及政府和非營利組織為提高意識所做的努力是推動該領域成長的關鍵因素。

預計有前景的新藥管道開發和用於治療 PTSD 的新藥的推出將在預測期內為市場成長提供有利的機會。目前，Aptinyx 的 NYX-783、Bionomics 的 BNC210 和 Jazz Pharmaceuticals 的 JZP150 正處於第 2 期臨床試驗階段。在此之前，競爭對手大塚製藥的Brexpiprazole和Zoloft都已進入第3階段臨床試驗，該領域產品上市的競爭非常主要企業。

新冠疫情等事件進一步推動了這一領域的成長。已經進行了多項研究，以了解 COVID-19 大流行對心理健康的影響、增加 PTSD 的風險和對其治療的需求。例如，2021 年 8 月的評論文章《COVID-19 與創傷後壓力症候群：心理健康的完美『風暴』」清楚地表明，受疫情影響的家庭和倖存者患創傷後壓力症候群的風險增加。

公司正在策略性地努力透過新產品開發、監管核准和地理擴張來加強產品系列。例如，2022 年 3 月，H. Lundbeck A/S 授予 Sun Pharmaceutical Industries Ltd.授權合約，在印度市場以 Vortidiftm 品牌名稱銷售沃替西汀。

創傷後壓力症候群治療市場報告重點

  • 2024 年，抗憂鬱症領域將由 FDA核准的SSRI 主導，例如 Zoloft（舍曲林）和 Paxil（帕羅西汀），預計在預測期內將保持其地位。
  • 根據人口統計數據，預計預測期內成人群體的複合年成長率將達到 5.1%，這是由於成年人口中該病的發病率上升、該年齡段患者佔大多數以及創傷經歷的增加。
  • 根據分銷管道，到 2024 年，零售藥局市場將佔據主導地位，原因是其易於獲得、與長期治療的居家照護相容等因素。
  • 由於公眾意識的增強、可支配收入的增加以及新興國家創傷後壓力症候群的盛行率高，預計亞太地區將在預測期內出現最快的成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 創傷後壓力症候群治療市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 創傷後壓力症候群治療市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析
  • 定價分析

第 4 章 創傷後壓力症候群治療市場：按藥物類別的估計和趨勢分析

  • 細分儀表板
  • 全球創傷後壓力症候群治療市場：藥物類別變化分析
  • 按藥品和類別分類的收益
  • 抗憂鬱症
  • 抗焦慮
  • 抗精神病藥物
  • 其他

5. 創傷後壓力症候群治療市場：人口統計、估計與趨勢分析

  • 細分儀表板
  • 全球創傷後壓力症候群治療市場：人口統計分析
  • 按人口統計和收益
  • 成人
  • 嬰兒
  • 老年人

6. 創傷後壓力症候群治療市場：按分銷管道分類的估計和趨勢分析

  • 細分儀表板
  • 全球創傷後壓力症候群治療市場：通路變化分析
  • 按分銷管道分類的收益
  • 醫院藥房
  • 零售藥局
  • 其他藥局

7. 創傷後壓力症候群治療市場：按藥物類別、人口統計和地區（按分銷管道）進行的估計和趨勢分析

  • 區域控制面板
  • 2018-2030 年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的近期趨勢及影響分析
  • 公司/競爭對手分類
  • 供應商概況
    • 2024 年主要企業的市場佔有率分析
    • AstraZeneca
    • GSK plc.
    • Pfizer Inc.
    • Otsuka Holdings Co., Ltd
    • Aurobindo Pharma
    • Merck KGaA
    • Jazz Pharmaceuticals, Inc.
    • Bionomics
    • Eli Lilly and Company
    • Viatris Inc.
Product Code: GVR-4-68039-997-2

Post-traumatic Stress Disorder Treatment Market Growth & Trends:

The global post-traumatic stress disorder treatment market size is anticipated to reach USD 2.85 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 4.08% from 2025 to 2030. The increasing disease burden of post-traumatic stress disorder (PTSD), innovation in R&D and emerging drug pipeline, and efforts by government and non-profit organizations to increase awareness are the key factors augmenting the space growth.

The emerging drug pipeline, thereby, expected advancement and drug launches for the treatment of PTSD, is anticipated to offer a lucrative opportunity for market growth over the forecast period. This can be attributed to the presence of Aptinyx's NYX-783, Bionomics' BNC210, and Jazz Pharmaceuticals' JZP150 under phase 2 clinical trials. Ahead of these, Otsuka Pharmaceutical's Brexpiprazole and Zoloft Combination are in phase 3 trial, creating fierce competition among key players to launch the product in the space.

Events such as the COVID-19 pandemic further support space growth. Several studies have been conducted to understand the impact of the covid 19 pandemic on mental health, increasing the risk of PTSD and rising demand for its treatment. For instance, the August 2021 review article, "COVID?19 and Post traumatic Stress Disorder: The Perfect 'Storm' for Mental Health," clearly demonstrates an increase in the risk of development of PTSD among pandemic affected families and survivors.

Companies are strategically taking initiatives that aid in developing new products, regulatory approvals, and enhancing their product portfolio with geographical expansion. For instance, in March 2022, H. Lundbeck A/S granted the license agreement to Sun Pharmaceutical Industries Ltd., for marketing and distribute of Vortioxetine under the brand name Vortidiftm in the Indian market.

Post-traumatic Stress Disorder Treatment Market Report Highlights:

  • In 2024, antidepressants segment accounted for the largest share and is anticipated to maintain its position over the forecast period owing to FDA approved SSRIs such as Zoloft (sertraline) and Paxil (paroxetine).
  • Based on demographics, adult segment is estimated to witness the fastest CAGR of 5.1% during the forecast period owing to presence of rising disorder incidence in adult group, major chunk of patients in this age group and increase in traumatic experiences.
  • Based on distribution channel, retail pharmacy segment dominated the space in 2024, due to factors such easy of availability, and its compatibility with homecare setting for the long term treatment.
  • Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increased awareness among the population, rise in disposable income, and high disease prevalence of PTSD in developing countries.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Demographics
    • 1.2.3. Distribution channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Drug class and demographics outlook
    • 2.2.2. Distribution channel outlook
  • 2.3. Competitive Insights

Chapter 3. Post-traumatic Stress Disorder Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High prevalence of post-traumatic stress disorder globally
      • 3.2.1.2. Rising investment in R&D
      • 3.2.1.3. Technological advancement
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations
      • 3.2.2.2. Side-effects associated with drug
  • 3.3. Post-traumatic Stress Disorder Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Pricing Analysis

Chapter 4. Post-traumatic Stress Disorder Treatment Market: Drug Class Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Post-traumatic Stress Disorder Treatment Market: Drug Class Movement Analysis
  • 4.3. Global Post-traumatic Stress Disorder Treatment Market Estimates and Forecasts, By Drug, Class Revenue (USD Million)
  • 4.4. Antidepressants
    • 4.4.1. Antidepressants market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Anti-anxiety
    • 4.5.1. Anti-anxiety market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Antipsychotics
    • 4.6.1. Antipsychotics market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Other Drug Class
    • 4.7.1. Others drug class market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Post-traumatic Stress Disorder Treatment Market: Demographics Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Post-traumatic Stress Disorder Treatment Market: Demographics Movement Analysis
  • 5.3. Global Post-traumatic Stress Disorder Treatment Market Estimates and Forecasts, By Demographics, Revenue (USD Million)
  • 5.4. Adult
    • 5.4.1. Adult market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Children
    • 5.5.1. Children market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Geriatric
    • 5.6.1. Geriatric market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Post-traumatic Stress Disorder Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Post-traumatic Stress Disorder Treatment Market: Distribution Channel Movement Analysis
  • 6.3. Global Post-traumatic Stress Disorder Treatment Market Estimates and Forecasts, by Distribution Channel, Revenue (USD Million)
  • 6.4. Hospitals Pharmacies
    • 6.4.1. Hospitals pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Other Pharmacies
    • 6.6.1. Other Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Post-traumatic Stress Disorder Treatment Market: Regional Estimates & Trend Analysis By Drug Clas, Demographics, and Distribution Channel

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2024
    • 8.3.2. AstraZeneca
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. GSK plc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Pfizer Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Otsuka Holdings Co., Ltd
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Aurobindo Pharma
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Merck KGaA
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Jazz Pharmaceuticals, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Bionomics
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Eli Lilly and Company
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Viatris Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 List of key distributors
  • Table 4 List of other companies
  • Table 5 List of key emerging company's/technology disruptors/innovators
  • Table 6 North America Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 7 North America Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 8 North America Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 9 North America Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 11 U.S. Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 12 U.S. Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Canada Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 14 Canada Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 15 Canada Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Mexico Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 17 Mexico Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 18 Mexico Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Europe Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 21 Europe Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 22 Europe Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 UK Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 24 UK Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 25 UK Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 Germany Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 27 Germany Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 28 Germany Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 France Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 30 France Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 31 France Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Spain Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 33 Spain Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 34 Spain Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 Italy Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 36 Italy Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 37 Italy Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Denmark Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 39 Denmark Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 40 Denmark Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Sweden Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 42 Sweden Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 43 Sweden Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Norway Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Norway Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 46 Norway Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Japan Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 51 Japan Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 52 Japan Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 China Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 54 China Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 55 China Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56 India Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 57 India Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 58 India Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59 Australia Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 60 Australia Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 61 Australia Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 South Korea Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 63 South Korea Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 64 South Korea Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65 Thailand Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 66 Thailand Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 67 Thailand Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 68 Latin America Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 70 Latin America Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 71 Latin America Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 72 Brazil Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 73 Brazil Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 74 Brazil Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 Argentina Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 76 Argentina Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 77 Argentina Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 78 MEA Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 79 MEA Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 80 MEA Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 81 MEA Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 South Africa Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 83 South Africa Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 84 South Africa Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 88 UAE Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 89 UAE Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 90 UAE Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 91 Kuwait Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Post-traumatic Stress Disorder Treatment market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Post-traumatic Stress disorder treatment market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook, revenue, 2024 (USD Million)
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Post-traumatic Stress disorder treatment market driver impact
  • Fig. 14 Post-traumatic Stress disorder treatment market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's Five Forces
  • Fig. 17 Post-traumatic Stress Disorder Treatment market: Drug class outlook and key takeaways
  • Fig. 18 Post-traumatic Stress disorder treatment market: Drug class movement analysis & market share 2024 & 2030
  • Fig. 19 Antidepressants market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Anti-anxiety market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Antipsychotics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Other drug class market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Post-traumatic stress disorder treatment market: Demographics outlook and key takeaways
  • Fig. 24 Post-traumatic stress disorder treatment market: Demographics movement analysis & market share 2024 & 2030
  • Fig. 25 Adult market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Children market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Geriatric market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Post-traumatic stress disorder treatment market: Distribution channel outlook and key takeaways
  • Fig. 29 Post-traumatic stress disorder treatment market: Distribution channel movement analysis & market share 2024 & 2030
  • Fig. 30 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Other pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Global post-traumatic stress disorder treatment market: Regional movement analysis
  • Fig. 34 Global post-traumatic stress disorder treatment market: Regional outlook and key takeaways
  • Fig. 35 Global post-traumatic stress disorder treatment market share and leading players
  • Fig. 36 North America, by country
  • Fig. 37 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. key country dynamics
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada key country dynamics
  • Fig. 41 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico key country dynamics
  • Fig. 43 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK key country dynamics
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany key country dynamics
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France key country dynamics
  • Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy key country dynamics
  • Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Spain key country dynamics
  • Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark key country dynamics
  • Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden key country dynamics
  • Fig. 58 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Norway key country dynamics
  • Fig. 60 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 China key country dynamics
  • Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Japan key country dynamics
  • Fig. 65 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 India key country dynamics
  • Fig. 67 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand key country dynamics
  • Fig. 69 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea key country dynamics
  • Fig. 71 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Australia key country dynamics
  • Fig. 73 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Brazil key country dynamics
  • Fig. 76 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Argentina key country dynamics
  • Fig. 78 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 South Africa key country dynamics
  • Fig. 81 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia key country dynamics
  • Fig. 83 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 UAE key country dynamics
  • Fig. 85 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Kuwait key country dynamics
  • Fig. 87 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Market share Analysis of key market players, 2024